Colorectal cancer

Cetuximab

Off

NICE appraisal

TA176 Cetuximab for the first line treatment of metastatic colorectal cancer (August 2009)

DSU reports

Cetuximab for the first line treatment of metastatic colorectal cancer: Addendum (PDF, 11KB) (May 2009)

Cetuximab for the first line treatment of metastatic colorectal cancer (PDF, 99KB) (March 2009)

Related information

Appraisal specific projects

A global reputation

Sheffield is a research university with a global reputation for excellence. We're a member of the Russell Group: one of the 24 leading UK universities for research and teaching.

About the University